Device
Contour Neurovascular System
Contour Neurovascular System is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Withdrawn1
Completed1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
withdrawn133%
completed133%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingphase_4
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
NCT04852783
withdrawn
Post Market Clinical Follow-up (PMCF)Study of the Contour Neurovascular SystemTM
NCT04579081
completednot_applicable
Contour Neurovascular System - European Pre-Market Unruptured Aneurysm
NCT03680742
Clinical Trials (3)
Showing 3 of 3 trials
NCT04852783Phase 4
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
NCT04579081
Post Market Clinical Follow-up (PMCF)Study of the Contour Neurovascular SystemTM
NCT03680742Not Applicable
Contour Neurovascular System - European Pre-Market Unruptured Aneurysm
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3